Skip to content

    The Montreal Heart Institute Receives $9.35 Million From the Quebec Government to Lead a Major Virtual Clinical Trial Project

    The Montreal Heart Institute (MHI) announces that it has won a request for proposals from the Fonds d’accélération des collaborations en santé (FACS). Pierre Fitzgibbon, Minister of Economic and Innovation, announced today a $9.35 million grant from the Government of Quebec to develop and deploy the project entitled Paradigm Shift in the Conduct of Clinical Trials.

    Launched by Dr. Jean-Claude Tardif, Director of the MHI Research Centre and Professor of Medicine at the Université de Montréal, this major public-private partnership initiative, worth more than $21.7 million, aims to develop a digital platform for conducting virtual clinical trials that do not require in-person visits.

    “Our teams at the Research Centre and the Montreal Health Innovations Coordinating Centre (MHICC) of the Montreal Heart Institute, as well as the team at Ecogène-21 are proud to mobilize a strong Quebec-wide network of public and private collaborators to lead this major initiative that addresses a critical need to transform traditional clinical trials,” said Dr. Tardif. “The use of new technologies in an integrated, patient-centered approach will allow patients to participate in clinical trials from the comfort of their own homes. This important paradigm shift will facilitate recruitment, retention and follow-up of participants while testing more potential therapies. Aimed at transforming the clinical trial environment in Quebec and around the world, this project has the potential to make Quebec a world leader in the field while accelerating value creation for our life sciences ecosystem, patients and healthcare system.”